Sanofi India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058A01010
  • NSEID: SANOFI
  • BSEID: 500674
INR
3,208.25
8.1 (0.25%)
BSENSE

Nov 20

BSE+NSE Vol: 9.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Aarti Pharma
Innova Captab
Blue Jet Health
Bliss GVS Pharma
Sanofi India
Strides Pharma
Orchid Pharma
SPARC
P & G Health Ltd
Sanofi Consumer
FDC
Why is Sanofi India Ltd ?
1
High Management Efficiency with a high ROE of 50.57%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of -9.43% and Operating profit at -8.20% over the last 5 years
4
Positive results in Sep 26
  • NET SALES(Q) Highest at Rs 491.70 cr
  • PBDIT(Q) Highest at Rs 161.20 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 32.78%
5
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
6
With ROE of 44.1, it has a Very Attractive valuation with a 8.9 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -29.77%, its profits have fallen by -1.7%
  • At the current price, the company has a high dividend yield of 3.8
7
High Institutional Holdings at 25.15%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
8
Below par performance in long term as well as near term
  • Along with generating -29.77% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Sanofi India should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sanofi India for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sanofi India
-29.77%
-1.21
24.58%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-9.43%
EBIT Growth (5y)
-8.20%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
2.25
Tax Ratio
25.75%
Dividend Payout Ratio
86.59%
Pledged Shares
0
Institutional Holding
25.15%
ROCE (avg)
118.75%
ROE (avg)
50.57%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
40
Price to Book Value
8.94
EV to EBIT
14.86
EV to EBITDA
13.80
EV to Capital Employed
14.90
EV to Sales
3.86
PEG Ratio
NA
Dividend Yield
3.83%
ROCE (Latest)
94.51%
ROE (Latest)
44.13%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
NET SALES(Q)

Highest at Rs 491.70 cr

PBDIT(Q)

Highest at Rs 161.20 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 32.78%

PBT LESS OI(Q)

Highest at Rs 152.20 cr.

PAT(Q)

Highest at Rs 116.70 cr.

EPS(Q)

Highest at Rs 50.74

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi India
Net Sales - Quarterly
Highest at Rs 491.70 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 161.20 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 32.78%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 152.20 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 152.20 cr has Grown at 37.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 111.13 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 116.70 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 116.70 cr has Grown at 35.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 86.02 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 50.74
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)